These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2571304)

  • 1. Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium.
    Baraban JM; Worley PF; Snyder SH
    Am J Psychiatry; 1989 Oct; 146(10):1251-60. PubMed ID: 2571304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inositol second messenger system.
    Vadnal RE
    Am J Psychiatry; 1990 Jul; 147(7):955. PubMed ID: 2356890
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the Na(+)-K(+)-ATPase the link between phosphoinositide metabolism and bipolar disorder?
    el-Mallakh RS; Li R
    J Neuropsychiatry Clin Neurosci; 1993; 5(4):361-8. PubMed ID: 8286932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
    Hyman SE; Nestler EJ
    Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular neurobiology for practicing psychiatrists, part 2: how neurotransmitters activate second messenger systems.
    Stahl SM
    J Clin Psychiatry; 1999 Oct; 60(10):647-8. PubMed ID: 10549679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief chronic effects of lithium administration on rat brain phosphoinositides and phospholipids.
    Navidi M; Yoa FG; Sun GY
    J Neurosci Res; 1991 Mar; 28(3):428-33. PubMed ID: 1649922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of the messenger systems in the altitude chamber hypoxia].
    Vishnevskiĭ AA; Iakovlev VM; Khabibullova ZI
    Biomed Khim; 2004; 50(2):187-91. PubMed ID: 15179826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of phosphatidylcholine breakdown.
    Exton JH
    Adv Second Messenger Phosphoprotein Res; 1990; 24():152-7. PubMed ID: 1976328
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of receptor coupling to phosphoinositide metabolism in the therapeutic action of lithium.
    Lenox RH
    Adv Exp Med Biol; 1987; 221():515-30. PubMed ID: 2829590
    [No Abstract]   [Full Text] [Related]  

  • 10. The phosphoinositide signalling system. I. Historical background. II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices.
    Hokin LE; Dixon JF
    Prog Brain Res; 1993; 98():309-15. PubMed ID: 8248520
    [No Abstract]   [Full Text] [Related]  

  • 11. The phosphoinositide second messenger system in human OPCA and the mouse model.
    Desaiah D; Subramony SH; Vig PJ; Currier RD
    Adv Neurol; 1993; 61():167-73. PubMed ID: 8380676
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
    Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
    J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its implications to rhythms in the brain.
    Nagayama H
    Pharmacol Ther; 1993; 59(1):31-54. PubMed ID: 7903122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hypothesis for the psycho-modulating effects of lithium: the role of essential fatty acids, eicosanoids and sub-cellular second messengers.
    Harvey BH; Carstens ME; Taljaard JJ
    Med Hypotheses; 1990 May; 32(1):51-8. PubMed ID: 2190069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical action mechanisms and pharmacokinetics of psychoactive drugs].
    Matussek N; Greil W
    Arzneimittelforschung; 1975 Jul; 25(7a):1178-84. PubMed ID: 1101905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of lithium: an update.
    Lenox RH; McNamara RK; Papke RL; Manji HK
    J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related differences in the phosphoinositide system in rat neostriatum.
    DasGupta K; Weiler MH
    Neuropsychopharmacology; 1992 Sep; 7(2):163-5. PubMed ID: 1329801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substance regulation of behavior].
    de Wied D
    Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1284-7. PubMed ID: 6136923
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oral lithium on the action of various C.N.S. active drugs.
    Awasthi PK; Garg HK; Srivastava VK; Singhal KC; Chattaraj T; Hasan M
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):241-4. PubMed ID: 8950140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of neurotransmitters and psychotropic drugs on the immune system. Mediator role of hormones and clinical implications].
    Martin-Du Pan RC; Dayer JM
    Schweiz Med Wochenschr; 1982 Dec; 112(52):1910-20. PubMed ID: 6131535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.